SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-004802
Filing Date
2024-01-18
Accepted
2024-01-18 16:04:40
Documents
12
Period of Report
2024-01-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm243561d1_8k.htm   iXBRL 8-K 26262
  Complete submission text file 0001104659-24-004802.txt   200340

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bdtx-20240117.xsd EX-101.SCH 3063
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdtx-20240117_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdtx-20240117_pre.xml EX-101.PRE 22391
6 EXTRACTED XBRL INSTANCE DOCUMENT tm243561d1_8k_htm.xml XML 3332
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39200 | Film No.: 24541797
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)